GlaxoSmithKline PLC (GSK) — Cash Flow-to-Debt Ratio
GlaxoSmithKline PLC (GSK) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of GBX2.22 Billion could theoretically repay 0% of its total liabilities (GBX45.59 Billion) in one year. Explore how much of GlaxoSmithKline PLC's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline PLC Cash Flow-to-Debt Ratio (1991–2024)
Historical debt coverage capacity for GlaxoSmithKline PLC across 35 annual periods. Also explore GSK asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline PLC (1991–2024)
Year-by-year debt coverage analysis for GlaxoSmithKline PLC. For market capitalisation and broader financial context, see GSK market cap.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | GBX6.55 Billion | GBX46.38 Billion | ▼ -3.5% |
| 2023 | 0.15x | GBX6.77 Billion | GBX46.21 Billion | ▼ -1.0% |
| 2022 | 0.15x | GBX7.40 Billion | GBX50.05 Billion | ▲ +7.4% |
| 2021 | 0.14x | GBX7.95 Billion | GBX57.76 Billion | ▼ -2.8% |
| 2020 | 0.14x | GBX8.44 Billion | GBX59.62 Billion | ▲ +8.3% |
| 2019 | 0.13x | GBX8.02 Billion | GBX61.34 Billion | ▼ -15.5% |
| 2018 | 0.15x | GBX8.42 Billion | GBX54.39 Billion | ▲ +18.4% |
| 2017 | 0.13x | GBX6.92 Billion | GBX52.89 Billion | ▲ +8.9% |
| 2016 | 0.12x | GBX6.50 Billion | GBX54.12 Billion | ▲ +108.3% |
| 2015 | 0.06x | GBX2.57 Billion | GBX44.57 Billion | ▼ -60.2% |
| 2014 | 0.14x | GBX5.18 Billion | GBX35.72 Billion | ▼ -31.2% |
| 2013 | 0.21x | GBX7.22 Billion | GBX34.27 Billion | ▲ +67.3% |
| 2012 | 0.13x | GBX4.38 Billion | GBX34.73 Billion | ▼ -35.0% |
| 2011 | 0.19x | GBX6.25 Billion | GBX32.25 Billion | ▼ -7.9% |
| 2010 | 0.21x | GBX6.80 Billion | GBX32.31 Billion | ▼ -13.8% |
| 2009 | 0.24x | GBX7.84 Billion | GBX32.12 Billion | ▲ +3.8% |
| 2008 | 0.24x | GBX7.31 Billion | GBX31.07 Billion | ▼ -14.4% |
| 2007 | 0.27x | GBX5.79 Billion | GBX21.09 Billion | ▲ +10.4% |
| 2006 | 0.25x | GBX3.96 Billion | GBX15.90 Billion | ▼ -12.6% |
| 2005 | 0.28x | GBX5.59 Billion | GBX19.63 Billion | ▲ +1.6% |
| 2004 | 0.28x | GBX4.77 Billion | GBX17.01 Billion | ▼ -11.1% |
| 2003 | 0.32x | GBX4.85 Billion | GBX15.40 Billion | ▲ +53.9% |
| 2002 | 0.20x | GBX3.06 Billion | GBX14.94 Billion | ▼ -39.7% |
| 2001 | 0.34x | GBX4.61 Billion | GBX13.57 Billion | ▲ +131.7% |
| 2000 | 0.15x | GBX1.85 Billion | GBX12.63 Billion | ▲ +107.9% |
| 1999 | 0.07x | GBX510.00 Million | GBX7.23 Billion | ▲ +13.1% |
| 1998 | 0.06x | GBX410.00 Million | GBX6.58 Billion | ▼ -33.6% |
| 1997 | 0.09x | GBX615.00 Million | GBX6.55 Billion | ▼ -22.0% |
| 1996 | 0.12x | GBX849.00 Million | GBX7.05 Billion | ▼ -19.9% |
| 1995 | 0.15x | GBX1.25 Billion | GBX8.32 Billion | ▼ -53.7% |
| 1995 | 0.33x | GBX2.45 Billion | GBX7.53 Billion | ▼ -15.4% |
| 1994 | 0.38x | GBX1.05 Billion | GBX2.74 Billion | ▲ +16.2% |
| 1993 | 0.33x | GBX927.00 Million | GBX2.80 Billion | ▲ +2.9% |
| 1992 | 0.32x | GBX657.00 Million | GBX2.04 Billion | ▲ +28.7% |
| 1991 | 0.25x | GBX615.00 Million | GBX2.46 Billion | — |